Our research within this theme identifies factors that play a role in chronic and infectious disease management, and the development of new treatments for common chronic conditions and disorders associated with ageing.
What sets our research apart?
Our research is relevant to the real world and stands on its own through:
- our expertise in advanced nursing research, based on direct links with hospitals, community services, residential aged care facilities and carers
- a focus on cancer - from genetic and biological studies that deal with onset and early diagnostics to initiatives that help people live healthy lives after treatment
- our expertise in molecular modelling to understand disease behaviour and progression
- partnerships with Australia's armed forces, Red Cross, Peter MacCallum Cancer Centre and pharma such as Sanofi and Hospira among others
- our strength in palliative care best practice and links with exercise and wellness
- our work at the Australian Prostate Cancer Research Centre to improve clinical management, develop diagnostics, therapeutics and treatments, and study biomarkers.
- our concerted effort across cancer types (prostate, breast, gynaecological cancers, lung, head and neck cancers) to improve diagnostics and therapeutics.
We work together in multidisciplinary teams on site, including hospitals and clinics where patients are treated, to provide first-hand interactions and experience. Our teams recognise the complexity of health issues and take into account social factors, human behaviour and genetic risk.
Our work within the chronic disease and ageing theme contributes to QUT's research in:
- Alzheimer's disease
- Healthy ageing, dementia and palliative care
- Chronic conditions management
- Infection and immunity
- Molecular medicine
- Vision and eye
Our research focuses on ailments that affect millions of people. Researchers are currently working to:
- develop new tests and targeted treatments for prostate cancer, several women's cancers, lung cancer and head and neck cancers
- complete a phase III clinical trial for a Ross River Arthritis vaccine
- undertake a clinical trial to study onset of cognitive impairment associated with Alzheimer's disease
- use the latest technology to study vision and light and their potential links to migraines, diabetes, ageing and dementia
- complete a national study of perceived quality of life for people living with dementia in residential aged care facilities
- lead national programs that improve palliative care and train healthcare professionals
- create programs and testing interventions to promote healthy behaviour for women with diabetes and cancer survivors.